NEW YORK (GenomeWeb) – The National Cancer Institute is seeking grant applications for research projects that will investigate and mitigate the challenges that pre-analytical biospecimen variability presents to clinical assay development.

As the starting material for biomarker assays, biospecimens are essential to personalized medicine. However, an increasing number of reports suggest that pre-analytical factors such as post-resection handling of clinical biospecimens can significantly impact assay results.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.